Literature DB >> 15586351

Angiotensin II receptor antagonists: role in hypertension, cardiovascular disease, and renoprotection.

Gerald B Appel1, Alice S Appel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15586351     DOI: 10.1016/j.pcad.2004.04.005

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  4 in total

Review 1.  The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases.

Authors:  Hazel Mae A Abraham; C Michael White; William B White
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

Review 2.  Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences.

Authors:  Sara Panizo; Laura Martínez-Arias; Cristina Alonso-Montes; Pablo Cannata; Beatriz Martín-Carro; José L Fernández-Martín; Manuel Naves-Díaz; Natalia Carrillo-López; Jorge B Cannata-Andía
Journal:  Int J Mol Sci       Date:  2021-01-02       Impact factor: 5.923

3.  Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril.

Authors:  G Bönner; G L Bakris; D Sica; M A Weber; W B White; A Perez; C Cao; A Handley; S Kupfer
Journal:  J Hum Hypertens       Date:  2013-03-21       Impact factor: 3.012

4.  Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry.

Authors:  Anselm K Gitt; Peter Bramlage; Sebastian A Potthoff; Peter Baumgart; Felix Mahfoud; Hartmut Buhck; Martina Ehmen; Taoufik Ouarrak; Jochen Senges; Roland E Schmieder
Journal:  BMC Cardiovasc Disord       Date:  2016-03-08       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.